Published in Infect Agent Cancer on November 25, 2009
Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res (2012) 1.76
High-risk human papillomavirus (HPV) screening and detection in healthy patient saliva samples: a pilot study. BMC Oral Health (2011) 0.98
New Concepts for Translational Head and Neck Oncology: Lessons from HPV-Related Oropharyngeal Squamous Cell Carcinomas. Front Oncol (2012) 0.95
An update on oral human papillomavirus infection. Indian J Sex Transm Dis (2013) 0.85
Role of human papillomavirus in oral squamous cell carcinoma and oral potentially malignant disorders: A review of the literature. Indian J Dent (2015) 0.83
Effectiveness of Toki's criteria and determination of variables for identification of HPV L1 protein in oral lesions. Med Oral Patol Oral Cir Bucal (2014) 0.75
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst (2000) 14.43
Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev (2005) 9.47
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst (2003) 6.28
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol (2006) 5.86
Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst (2000) 5.32
Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol (2006) 4.66
Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst (2004) 3.67
Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev (2004) 3.52
The papillomavirus life cycle. J Clin Virol (2005) 3.41
Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis (2004) 3.04
Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr (2003) 2.87
Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer (2007) 2.37
Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2001) 2.24
A causal role for human papillomavirus in head and neck cancer. Lancet (2004) 2.21
Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene (2002) 2.09
Animal models of papillomavirus pathogenesis. Virus Res (2002) 1.98
Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer (2001) 1.85
Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer (2001) 1.82
Risk factors for oral human papillomavirus in adults infected and not infected with human immunodeficiency virus. Sex Transm Dis (1997) 1.71
Biology of HPV in HIV infection. Adv Dent Res (2006) 1.61
New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer (2002) 1.60
Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer (2003) 1.57
Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res (2002) 1.53
Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women. J Clin Microbiol (2006) 1.46
Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol (2007) 1.41
"High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol (2000) 1.33
Immunogenetics of viral infections. Curr Opin Immunol (2005) 1.33
The role of human papillomavirus in oral carcinogenesis. Crit Rev Oral Biol Med (2004) 1.31
Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J Dent Res (2009) 1.31
Human papillomavirus in HNSCC: recognition of a distinct disease type. Hematol Oncol Clin North Am (2008) 1.28
The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults. Sex Transm Dis (2005) 1.26
Incidence of oral lesions in HIV-1-infected women: reduction with HAART. J Dent Res (2004) 1.25
Trigeminal neuralgia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2005) 1.22
Replication and assembly of human papillomaviruses. J Dent Res (2009) 1.20
Oral erythroplakia--a review. Oral Oncol (2005) 1.18
Novel HPV types present in oral papillomatous lesions from patients with HIV infection. Int J Cancer (1996) 1.12
Human papillomaviruses in head and neck carcinomas. N Engl J Med (2007) 1.10
Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome. Cancer Lett (2007) 1.07
Human papillomavirus infections and oral tumors. Med Microbiol Immunol (2003) 1.05
The spectrum and clinical sequelae of human papillomavirus infection. Gynecol Oncol (2007) 1.05
HPV DNA in clinically different variants of oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2004) 1.01
Association between proliferative verrucous leukoplakia and infection with human papillomavirus type 16. J Oral Pathol Med (1995) 0.99
Biopsy vs. superficial scraping: detection of human papillomavirus 6, 11, 16, and 18 in potentially malignant and malignant oral lesions. J Oral Pathol Med (2006) 0.96
DNA viruses in human cancer: an integrated overview on fundamental mechanisms of viral carcinogenesis. Cancer Lett (2006) 0.96
HPV-related neoplasias in HIV-infected individuals. Eur J Cancer (2001) 0.94
Human papillomavirus 6/11, 16 and 18 in oral carcinomas and benign oral lesions. Med Microbiol Immunol (2002) 0.94
Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2006) 0.92
Role of the human papilloma virus in the development of cervical intraepithelial neoplasia and malignancy. Postgrad Med J (2002) 0.89
Oral HPV complications in HIV-infected patients. Curr HIV/AIDS Rep (2008) 0.89
Molecular piracy: the viral link to carcinogenesis. Oral Oncol (1998) 0.89
The viral etiology of AIDS-associated malignancies. Adv Pharmacol (2008) 0.89
Human papillomavirus type 16 and 18 DNA in oral squamous cell carcinoma and normal mucosa. Int J Oral Maxillofac Surg (2004) 0.87
Human papillomavirus in oral premalignant lesions. Eur J Cancer B Oral Oncol (1996) 0.86
HPV-associated diseases of oral mucosa. Clin Dermatol (1997) 0.82
Pleiotropic mechanisms of virus survival and persistence. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2005) 0.82
Oral wart associated with human papillomavirus type 2. J Oral Pathol Med (1999) 0.80
Detection of HPV DNA in oral carcinoma using polymerase chain reaction together with in situ hybridization. Oral Surg Oral Med Oral Pathol (1994) 0.79
Prevalence of human papillomavirus in squamous cell carcinoma of the tongue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2007) 0.76
Human papillomavirus, type 40-associated papilloma, and concurrent Kaposi's sarcoma involving the anterior hard palate of an HIV-positive man. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2003) 0.76
The nature of fibrous dysplasia. Head Face Med (2009) 1.24
Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma. Head Face Med (2010) 1.09
HIV-associated oral Kaposi sarcoma and HHV-8: a review. J Int Acad Periodontol (2007) 0.98
Necrotizing periodontal diseases in HIV-seropositive subjects: pathogenic mechanisms. J Int Acad Periodontol (2008) 0.96
Human immunodeficiency virus-associated Kaposi sarcoma as an immune reconstitution inflammatory syndrome: a literature review and case report. J Periodontol (2008) 0.95
Actinic cheilitis: a case report and a review of the literature. Eur J Dent (2011) 0.93
Herpes zoster infection as an immune reconstitution inflammatory syndrome in HIV-seropositive subjects: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2007) 0.93
Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma. Infect Agent Cancer (2008) 0.90
Melanin: the biophysiology of oral melanocytes and physiological oral pigmentation. Head Face Med (2014) 0.88
Complex oral manifestations of an HIV-seropositive patient. J Int Acad Periodontol (2006) 0.86
Extranodal natural killer/T-cell lymphoma, nasal type: 'midline lethal granuloma.' A case report. Head Face Med (2013) 0.85
HIV-associated Kaposi sarcoma: pathogenic mechanisms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2007) 0.84
A short account of metastatic bone disease. Cancer Cell Int (2011) 0.84
Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 1: human papillomavirus-mediated carcinogenesis. Head Face Med (2010) 0.81
Necrotizing periodontal diseases in a semirural district of South Africa. AIDS Res Treat (2011) 0.81
A Comparison of Chronic Periodontitis in HIV-Seropositive Subjects and the General Population in the Ga-Rankuwa Area, South Africa. AIDS Res Treat (2012) 0.81
Multiple congenital oral granular cell tumours in a newborn black female: a case report. Cases J (2008) 0.79
Melanocyte biology and function with reference to oral melanin hyperpigmentation in HIV-seropositive subjects. AIDS Res Hum Retroviruses (2014) 0.79
Extramedullary myeloma in an HIV-seropositive subject. Literature review and report of an unusual case. Head Face Med (2009) 0.79
Pathobiology of cancer metastasis: a short account. Cancer Cell Int (2012) 0.79
Oral ulcers and necrotizing gingivitis in relation to HIV-associated neutropenia: a review and an illustrative case. AIDS Res Hum Retroviruses (2011) 0.78
Human immunodeficiency virus (HIV)-associated extranodal T cell non-Hodgkin lymphoma of the oral cavity. SADJ (2008) 0.78
Noma and cervicofacial necrotizing fasciitis: clinicopathological differentiation and an illustrative case report of noma. AIDS Res Hum Retroviruses (2014) 0.77
Report of a black South African child with oculodentodigital dysplasia and a novel GJA1 gene mutation. Am J Med Genet A (2008) 0.77
Proliferative verrucous leukoplakia and field cancerization: report of a case. J Int Acad Periodontol (2006) 0.76
The association between human herpesviruses and periodontal disease: Part 1. Herpesviruses immune evasion. A review. SADJ (2007) 0.75
Discoid lupus erythematosus-related squamous cell carcinoma of the lip in an HIV-seropositive black male. J Cancer Res Ther (2016) 0.75
Immunopathogenic Oral Diseases: An Overview Focusing on Pemphigus Vulgaris and Mucous Membrane Pemphigoid. Oral Health Prev Dent (2017) 0.75